OncoPharm
John Bossaer
Add to My Podcasts
Episodes
About
Reviews
Promote
Instant KarMMa
12 minutes
Posted Feb 16, 2023 at 7:24 pm.
0:00
12:18
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Ide-Cel vs. "standard" treatment in relapsed/refreactory multiple myeloma study - the KarMMa-3 trial - is discussed.
Link: https://www.nejm.org/doi/full/10.1056/NEJMoa2213614
Previous
CodeBreak200 And Elderly AML Survival
Next
Cannabis Use With ICIs
← See all 273 episodes of OncoPharm